Literature DB >> 9081996

Trends in surgical treatment of Class III skeletal relationships.

L T Bailey1, W R Proffit, R P White.   

Abstract

A review of a surgical-orthodontic database revealed striking changes in the surgical treatment of skeletal Class III problems. After its development, ramus osteotomy for mandibular setback became the standard procedure and was still used in nearly half the patients treated in 1978 to 1985. Between 1985 and 1990, the number of isolated mandibular setback procedures dropped sharply, while the number of maxillary advancements nearly doubled. The number of patients undergoing combined maxillary and mandibular surgery also increased. In 1990 to 1992, isolated mandibular setback was used in fewer than 10% of the patients, while maxillary advancement was used in more than 40% of the patients. The changes were influenced by improvements in surgical techniques, the demonstration that maxillary advancement is unlikely to cause speech problems in noncleft patients, and documentation that better esthetics and stability can be achieved with maxillary than with mandibular surgery.

Entities:  

Mesh:

Year:  1995        PMID: 9081996

Source DB:  PubMed          Journal:  Int J Adult Orthodon Orthognath Surg        ISSN: 0742-1931


  9 in total

1.  Stability after mandibular setback: mandible-only versus 2-jaw surgery.

Authors:  William R Proffit; Ceib Phillips; Timothy A Turvey
Journal:  J Oral Maxillofac Surg       Date:  2012-02-24       Impact factor: 1.895

2.  Long-term outcome of surgical Class III correction as a function of age at surgery.

Authors:  L'Tanya J Bailey; Ceib Phillips; William R Proffit
Journal:  Am J Orthod Dentofacial Orthop       Date:  2008-03       Impact factor: 2.650

3.  The Direction of Double-Jaw Surgery Relapse for Correction of Skeletal Class III Deformity: Bilateral Sagittal Split Versus Intraoral Vertical Ramus Setback Osteotomies.

Authors:  Ra'ed Mohammed Ayoub Al-Delayme; Ali Arkan Redha Alsagban; Fires Taha Ahmed; Ahmad Farag; Tumouh Al-Allaq; Parveen Virdee; Zaid Alnajjar; Sufian Alaa Ibraheem Alsamaraie; Salih Elnashef; Layla Arab; Alaa Yassin; Moutaz Al-Khen
Journal:  J Maxillofac Oral Surg       Date:  2018-06-04

4.  Adult Class III treatment using a J-hook headgear to the mandibular arch.

Authors:  Yasuko Kuroda; Shingo Kuroda; Richard G Alexander; Eiji Tanaka
Journal:  Angle Orthod       Date:  2010-03       Impact factor: 2.079

5.  Three-dimensional changes of the hyoid bone and airway volumes related to its relationship with horizontal anatomic planes after bimaxillary surgery in skeletal Class III patients.

Authors:  Min-Ah Kim; Bo-Ram Kim; Jin-Young Choi; Jong-Kuk Youn; Yoon-Ji R Kim; Yang-Ho Park
Journal:  Angle Orthod       Date:  2013-01-11       Impact factor: 2.079

6.  Long-term stability of surgical-orthodontic correction of class III malocclusions with long-face syndrome.

Authors:  David Gallego-Romero; José-María Llamas-Carrera; Daniel Torres-Lagares; Vanessa Paredes; Eduardo Espinar; Eduardo Guevara; José-Luis Gutiérrez-Pérez
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2012-05-01

7.  Management of severe skeletal Class III malocclusion with bimaxillary orthognathic surgery.

Authors:  Jitesh Haryani; Amit Nagar; Divya Mehrotra; Rani Ranabhatt
Journal:  Contemp Clin Dent       Date:  2016 Oct-Dec

8.  Ortho-surgical management of a Conradi-Hünermann syndrome patient: rare case report.

Authors:  Leopoldino Capelozza Filho; Mauricio de Almeida Cardoso; Eduardo José Caldeira; Anderson Capistrano; Aldir da Silva Cordeiro; Diógenes Rocha
Journal:  Clin Case Rep       Date:  2015-06-29

9.  Comparison of one-jaw and two-jaw orthognathic surgery in patients with skeletal Class III malocclusion using data from 10 multi-centers in Korea: Part I. Demographic and skeletodental characteristics.

Authors:  Seung-Weon Lim; Minsoo Kim; Mihee Hong; Kyung-Hwa Kang; Minji Kim; Su-Jung Kim; Yoon-Ji Kim; Young Ho Kim; Sung-Hoon Lim; Sang Jin Sung; Seung-Hak Baek; Jin-Hyoung Cho
Journal:  Korean J Orthod       Date:  2022-01-25       Impact factor: 1.372

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.